Detalles de la búsqueda
1.
Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness.
Hepatology
; 77(2): 558-572, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35712786
2.
Steatotic liver disease is the most important somatic determinant of quality of life in patients with obesity: A cross-sectional study.
Liver Int
; 44(1): 191-201, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37904634
3.
Only one-third of referrals for fatty liver disease are on time: real-world study reveals opportunities to avoid unnecessary and delayed referrals.
Scand J Gastroenterol
; 57(12): 1478-1485, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35793386
4.
Are Nonalcoholic Fatty Liver Disease and Bone Mineral Density Associated? - A Cross-Sectional Study Using Liver Biopsy and Dual-Energy X-Ray Absorptiometry.
JBMR Plus
; 7(3): e10714, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36936359
5.
Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives.
J Clin Med
; 10(4)2021 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33572481
6.
Validation of a Simple Quality-of-Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy.
Hepatol Commun
; 4(9): 1353-1361, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32923838
7.
Reply to Letter to the Editor: Neurocognitive impairment in obesity and liver disease-An unsolved mystery.
Hepatol Commun
; 7(11)2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37902471
Resultados
1 -
7
de 7
1
Próxima >
>>